8-K//Current report
CASI Pharmaceuticals, Inc. 8-K
Accession 0001104659-22-118471
CIK 0000895051operating
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 4:00 PM ET
Size
363.7 KB
Accession
0001104659-22-118471
Documents
- 8-Ktm2228810d1_8k.htmPrimary
FORM 8-K
- EX-99.1tm2228810d1_ex99-1.htm
EXHIBIT 99.1
- EX-101.SCHcasi-20221114.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABcasi-20221114_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREcasi-20221114_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- GRAPHICtm2228810d1_ex99-1img001.jpg
GRAPHIC
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLtm2228810d1_8k_htm.xml
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001104659-22-118471-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
CASI Pharmaceuticals, Inc (DE)
CIK 0000895051
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000895051
Filing Metadata
- Form type
- 8-K
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 4:00 PM ET
- Size
- 363.7 KB